Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in Belgium.
Werbrouck J, Bouche G, de Jonge E, Jacomen G, D'Hondt V, Denys H, Van Limbergen E, Vandermeersch B, De Schutter H, Van Eycken E, Goffin F, Amant F. Werbrouck J, et al. Among authors: amant f. Gynecol Oncol. 2013 Dec;131(3):512-9. doi: 10.1016/j.ygyno.2013.10.001. Epub 2013 Oct 6. Gynecol Oncol. 2013. PMID: 24103471 Free article.
Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.
Coosemans A, Nik SA, Caluwaerts S, Lambin S, Verbist G, Van Bree R, Schelfhout V, de Jonge E, Dalle I, Jacomen G, Cassiman JJ, Moerman P, Vergote I, Amant F. Coosemans A, et al. Among authors: amant f. Eur J Cancer. 2007 Jul;43(10):1630-7. doi: 10.1016/j.ejca.2007.04.008. Epub 2007 May 24. Eur J Cancer. 2007. PMID: 17531467 Free article.
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
Despierre E, Vergote I, Anderson R, Coens C, Katsaros D, Hirsch FR, Boeckx B, Varella-Garcia M, Ferrero A, Ray-Coquard I, Berns EM, Casado A, Lambrechts D, Jimeno A; European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG); Groupe d’Investigateurs Nationaux pour les Etudes des Cancers de l’Ovaire (GINECO); Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (A-AGO); National Cancer Research Institute (NCRI); Australia New Zealand Gynaecological Oncology Group (ANZGOG); Mario Negri Gynecologic Oncology group (MaNGO). Despierre E, et al. Target Oncol. 2015 Dec;10(4):583-96. doi: 10.1007/s11523-015-0369-6. Target Oncol. 2015. PMID: 26004768 Free PMC article. Clinical Trial.
Uterine carcinosarcoma with melanocytic differentiation.
Amant F, Moerman P, Davel GH, De Vos R, Vergote I, Lindeque BG, de Jonge E. Amant F, et al. Int J Gynecol Pathol. 2001 Apr;20(2):186-90. doi: 10.1097/00004347-200104000-00012. Int J Gynecol Pathol. 2001. PMID: 11293166
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F, Steenkiste E, Schurmans K, Verbist L, Abeler VM, Tulunay G, de Jonge E, Massuger L, Moerman P, Vergote I. Amant F, et al. Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1118-21. doi: 10.1111/j.1048-891X.2004.14610.x. Int J Gynecol Cancer. 2004. PMID: 15571618
593 results